IL6 and autoimmune thrombocytopenic purpura: Patients with the risk variant receiving anti-D intravenous antibodies, which are antibodies to Rho(D) present on some RBCs, for ITP, have higher plasma levels of IL-6, TNFα, and MCP-1 post-infusion compared to patients with the non-risk variant (27).